Abstract
BACKGROUND: At present, studies on MircoRNA-22-3p (miR-22-3p) in lung adenocarcinoma use a single method, lack multi-center validation and multi-metho......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
